United States Securities and Exchange Commission v. Cba Pharma Inc

Court

District Court, E.D. Kentucky (E.D. Ky.)
Official Court Website →

Assigned judge

Karen K. Caldwell · 1,468 cases in index

Docket number

5:26-cv-00042

Cause

15:77 Securities Fraud
15 U.S.C. § 77 — Securities Act of 1933

Nature of suit

850 Securities/Commodities
Alleged violations of federal securities or commodities laws.

Jurisdiction

U.S. Government Plaintiff

Jury demand

Plaintiff

Date filed

02/05/2026

108 Securities / Commodities cases in this court are indexed here.

Parties

• plaintiff · United States Securities and Exchange Commission · 541 cases
• defendant · Cba Pharma Inc

Part of a Larger Litigation Pattern

This is one of 2 Securities / Commodities cases in our index naming CBA Pharma Inc — a possible mass-tort or coordinated-litigation cluster.

About Securities / Commodities Lawsuits

Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

Frequently Asked Questions

What is United States Securities and Exchange Commission v. Cba Pharma Inc?

United States Securities and Exchange Commission v. Cba Pharma Inc is a federal securities / commodities lawsuit filed on 02/05/2026 in the District Court, E.D. Kentucky. The case is currently open in the federal court system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What type of case is this?

It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What court is the case in?

The case is in the District Court, E.D. Kentucky, docket number 5:26-cv-00042.

When was the case filed?

United States Securities and Exchange Commission v. Cba Pharma Inc was filed on 02/05/2026. The case is currently open.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 77 — Securities Act of 1933.